Literature DB >> 33264816

COVID-19 in older adults: What are the differences with younger patients?

Ana B Gómez-Belda1, Mar Fernández-Garcés1, Elisabeth Mateo-Sanchis1, Manuel Madrazo1, Mar Carmona1, Laura Piles-Roger1, Arturo Artero1,2.   

Abstract

AIM: The present study aimed both to gain knowledge on the distinctive clinical characteristics of older adults with coronavirus disease 2019 (COVID-19), in comparison with those of younger patients, and to identify risk factors for mortality.
METHODS: A retrospective observational study was carried out of patients consecutively admitted to Doctor Peset University Hospital, Valencia (Spain) for COVID-19 from 11 March to 28 April 2020. Every case was diagnosed by reverse transcription polymerase chain reaction or by serology test to detect antibodies. Demographic details, clinical characteristics, laboratory findings on admission and complications of each case were collected from electronic medical records.
RESULTS: The dataset comprised 340 patients. Of them, 152 (44.6%) were aged >70 years. Comorbidities were more common in the older groups. Confusion was more common in older adults, whereas typical symptoms of COVID-19, such as fever, cough and myalgia, were less common. Oxygen saturation ≤93% on room air, neutrophilia, D-dimer >0.5 μg/mL, creatinine >1.5 mg/dL, lactate dehydrogenase ≥250 U/L and elevation of creatine kinase were higher in the older adult groups. Complications during hospitalization, such as acute respiratory distress syndrome (53.3% vs 33.2%, P < 0.001), acute kidney injury (11.8% vs 5.3%; P = 0.030) and mortality (28.9% vs 6.5%; P < 0.001) were more common in patients aged >70 years. Oxygen saturation ≤93% on room air on admission was a predictor of mortality (odds ratio 11.65, 95% confidence interval 3.26-41.66, P < 0.001) in patients aged >70 years.
CONCLUSIONS: Older adults with COVID-19 have more atypical presentation, more complications and higher mortality. Oxygen saturation ≤93% on room air on admission is a predictive factor of death. Geriatr Gerontol Int 2020; ••: ••-••.
© 2020 Japan Geriatrics Society.

Entities:  

Keywords:  COVID-19; clinical characteristics; coronavirus; mortality; older adults

Year:  2020        PMID: 33264816     DOI: 10.1111/ggi.14102

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  16 in total

1.  Barthel's Index: A Better Predictor for COVID-19 Mortality Than Comorbidities.

Authors:  João Cordeiro da Costa; Maria Conceição Manso; Susana Gregório; Márcia Leite; João Moreira Pinto
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-06-23

2.  Comorbidity-adjusted NEWS predicts mortality in suspected patients with COVID-19 from nursing homes: Multicentre retrospective cohort study.

Authors:  Francisco Martín-Rodríguez; Ancor Sanz-García; Laura Melero Guijarro; Guillermo J Ortega; Marta Gómez-Escolar Pérez; Miguel A Castro Villamor; Julio C Santos Pastor; Juan F Delgado Benito; Raúl López-Izquierdo
Journal:  J Adv Nurs       Date:  2021-09-14       Impact factor: 3.057

Review 3.  Clinical Features of SARS-CoV-2 Infection in Older Adults.

Authors:  Francesca Remelli; Stefano Volpato; Caterina Trevisan
Journal:  Clin Geriatr Med       Date:  2022-03-21       Impact factor: 3.529

Review 4.  COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy Making.

Authors:  Chih-Kuang Liang; Wei-Ju Lee; Li-Ning Peng; Lin-Chieh Meng; Fei-Yuan Hsiao; Liang-Kung Chen
Journal:  Clin Geriatr Med       Date:  2022-03-21       Impact factor: 3.529

5.  Longitudinal Analysis and Comparison of Six Serological Assays up to Eight Months Post-COVID-19 Diagnosis.

Authors:  Aurélien Aubry; Baptiste Demey; Catherine François; Gilles Duverlie; Sandrine Castelain; François Helle; Etienne Brochot
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

6.  [Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients].

Authors:  S Ortonobes Roig; N Soler-Blanco; I Torrente Jiménez; E Van den Eynde Otero; M Moreno-Ariño; M Gómez-Valent
Journal:  Rev Esp Quimioter       Date:  2021-02-01       Impact factor: 1.553

7.  Age-Related Risk Factors and Complications of Patients With COVID-19: A Population-Based Retrospective Study.

Authors:  Han Zhang; Yingying Wu; Yuqing He; Xingyuan Liu; Mingqian Liu; Yuhong Tang; Xiaohua Li; Guang Yang; Gang Liang; Shabei Xu; Minghuan Wang; Wei Wang
Journal:  Front Med (Lausanne)       Date:  2022-01-11

8.  Does the COVID-19 seroconversion in older adults resemble the young?

Authors:  Rabia Bag Soytas; Mahir Cengiz; Mehmet Sami Islamoglu; Betul Borku Uysal; Hande Ikitimur; Hakan Yavuzer; Serap Yavuzer
Journal:  J Med Virol       Date:  2021-06-03       Impact factor: 20.693

9.  Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study.

Authors:  D F Bavaro; L Diella; C Fabrizio; R Sulpasso; I F Bottalico; A Calamo; C R Santoro; G Brindicci; G Bruno; A Mastroianni; G B Buccoliero; S Carbonara; S Lo Caputo; T Santantonio; L Monno; G Angarano; A Saracino
Journal:  Int J Infect Dis       Date:  2021-03-17       Impact factor: 3.623

10.  Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study.

Authors:  Liane S Canas; Carole H Sudre; Joan Capdevila Pujol; Lorenzo Polidori; Benjamin Murray; Erika Molteni; Mark S Graham; Kerstin Klaser; Michela Antonelli; Sarah Berry; Richard Davies; Long H Nguyen; David A Drew; Jonathan Wolf; Andrew T Chan; Tim Spector; Claire J Steves; Sebastien Ourselin; Marc Modat
Journal:  Lancet Digit Health       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.